Sipai Health Technology Co (FRA:AX1) YoY EPS Growth: 78.43% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AX1 Sipai Health Technology Co Ltd FRA:AX1
60 GF Score
Price €0.15
GF Value €0.23
! 5 Warning Signs
View Full Analysis

What is Sipai Health Technology Co YoY EPS Growth?

Sipai Health Technology Co FRA:AX1 +2.03% 60 YoY EPS Growth is 78.43% as of Dec. 2025. GuruFocus rates FRA:AX1 with a GF Score™ of 60/100 and a GF Value™ of €0.23. The stock has 5 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Sipai Health Technology Co's YoY EPS Growth for the quarter that ended in Dec. 2025 was 78.43%.

Sipai Health Technology Co's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was €-0.01.

Sipai Health Technology Co YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Sipai Health Technology Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sipai Health Technology Co YoY EPS Growth Chart

Sipai Health Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial -295.93 -142.44 96.91 -31.37 62.69

Sipai Health Technology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.67 -54.55 6.67 78.43 164.29
FRA:AX1
60GF Score
Sipai Health Technology Co Ltd FRA:AX1
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sipai Health Technology Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Sipai Health Technology Co's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(-0.025--0.067)/ | -0.067 |
=62.69 %

Sipai Health Technology Co's YoY EPS Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EPS Growth (Q: Dec. 2025 )
=(Earnings per Share (Diluted) (Q: Dec. 2025 )-Earnings per Share (Diluted) (Q: Dec. 2024 )) / | Earnings per Share (Diluted) (Q: Dec. 2024 )) |
=(-0.011--0.051)/ | -0.051 |
=78.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 78.43% mean?
Sipai Health Technology Co (FRA:AX1) has a YoY EPS Growth of 78.43% as of Dec. 2025. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Sipai Health Technology Co and its competitors.
Is Sipai Health Technology Co's YoY EPS Growth too high?
Sipai Health Technology Co's current YoY EPS Growth is 78.43%. Overall, Sipai Health Technology Co has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's YoY EPS Growth compare to MCK and COR?
Sipai Health Technology Co's YoY EPS Growth of 78.43% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Medical Distribution company?
A good YoY EPS Growth depends on the Medical Distribution industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Sipai Health Technology Co and its competitors. Sipai Health Technology Co's current YoY EPS Growth is 78.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Sipai Health Technology Co (FRA:AX1) has a current YoY EPS Growth of 78.43%. The stock's GF Value™ is €0.23, compared to a current price of €0.15 — trading 34.3% below its estimated fair value. The current YoY EPS Growth is 78.43%. Sipai Health Technology Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Sipai Health Technology Co (FRA:AX1), the current YoY EPS Growth is 78.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sipai Health Technology Co (FRA:AX1) Overvalued in 2026?

Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued. The current stock price of €0.15 is trading 34.3% below its estimated GF Value™ of €0.23.

Key valuation signals for FRA:AX1:

  • YoY EPS Growth: 78.43%
  • GF Value™: €0.23 vs. price of €0.15 (34.3% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the FRA:AX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sipai Health Technology Co Business Description

Other Exchanges 00314:Hong Kong
Address 128 Tianmu West Road, 1603-1605A, 16th Floor, Tower 1, Kerry Enterprise Center, Jing\'an District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
60GF Score

Get the complete analysis for FRA:AX1

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price
€0.23
GF Value